annual FCF:
$171.23M+$60.69M(+54.91%)Summary
- As of today (May 24, 2025), SUPN annual free cash flow is $171.23 million, with the most recent change of +$60.69 million (+54.91%) on December 31, 2024.
- During the last 3 years, SUPN annual FCF has risen by +$46.14 million (+36.89%).
- SUPN annual FCF is now at all-time high.
Performance
SUPN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$30.27M-$13.92M(-31.50%)Summary
- As of today (May 24, 2025), SUPN quarterly free cash flow is $30.27 million, with the most recent change of -$13.92 million (-31.50%) on March 31, 2025.
- Over the past year, SUPN quarterly FCF has dropped by -$7.88 million (-20.66%).
- SUPN quarterly FCF is now -66.89% below its all-time high of $91.42 million, reached on June 30, 2020.
Performance
SUPN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$163.34M-$7.88M(-4.60%)Summary
- As of today (May 24, 2025), SUPN TTM free cash flow is $163.34 million, with the most recent change of -$7.88 million (-4.60%) on March 31, 2025.
- Over the past year, SUPN TTM FCF has increased by +$63.51 million (+63.61%).
- SUPN TTM FCF is now -8.29% below its all-time high of $178.10 million, reached on June 30, 2020.
Performance
SUPN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
SUPN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.9% | -20.7% | +63.6% |
| 3 y3 years | +36.9% | +777.2% | +73.2% |
| 5 y5 years | +20.8% | +374.6% | +41.6% |
SUPN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +54.9% | -57.8% | +259.1% | -5.0% | +129.8% |
| 5 y | 5-year | at high | +54.9% | -66.9% | +259.1% | -8.3% | +129.8% |
| alltime | all time | at high | +387.3% | -66.9% | +256.3% | -8.3% | +345.3% |
SUPN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $30.27M(-31.5%) | $163.34M(-4.6%) |
| Dec 2024 | $171.23M(+54.9%) | $44.19M(-17.1%) | $171.23M(-0.5%) |
| Sep 2024 | - | $53.32M(+49.9%) | $172.03M(+11.4%) |
| Jun 2024 | - | $35.56M(-6.8%) | $154.43M(+54.7%) |
| Mar 2024 | - | $38.15M(-15.2%) | $99.84M(-9.7%) |
| Dec 2023 | $110.53M(-5.1%) | $44.99M(+25.9%) | $110.53M(+18.7%) |
| Sep 2023 | - | $35.73M(-287.7%) | $93.11M(+31.0%) |
| Jun 2023 | - | -$19.03M(-139.0%) | $71.08M(-56.1%) |
| Mar 2023 | - | $48.85M(+77.2%) | $161.81M(+39.0%) |
| Dec 2022 | $116.41M(-6.9%) | $27.57M(+101.4%) | $116.41M(-15.4%) |
| Sep 2022 | - | $13.69M(-80.9%) | $137.56M(+14.9%) |
| Jun 2022 | - | $71.69M(+1977.5%) | $119.72M(+27.0%) |
| Mar 2022 | - | $3.45M(-92.9%) | $94.29M(-24.6%) |
| Dec 2021 | $125.08M(-7.1%) | $48.72M(-1272.9%) | $125.08M(+15.8%) |
| Sep 2021 | - | -$4.15M(-109.0%) | $107.98M(-8.0%) |
| Jun 2021 | - | $46.27M(+35.1%) | $117.43M(-27.8%) |
| Mar 2021 | - | $34.24M(+8.3%) | $162.57M(+20.7%) |
| Dec 2020 | $134.71M(-5.0%) | $31.62M(+497.0%) | $134.71M(-7.9%) |
| Sep 2020 | - | $5.30M(-94.2%) | $146.20M(-17.9%) |
| Jun 2020 | - | $91.42M(+1333.1%) | $178.10M(+54.4%) |
| Mar 2020 | - | $6.38M(-85.2%) | $115.35M(-18.6%) |
| Dec 2019 | $141.74M(+10.6%) | $43.11M(+15.9%) | $141.74M(+7.9%) |
| Sep 2019 | - | $37.20M(+29.8%) | $131.38M(-16.0%) |
| Jun 2019 | - | $28.66M(-12.5%) | $156.44M(+16.7%) |
| Mar 2019 | - | $32.77M(+0.1%) | $134.03M(+4.6%) |
| Dec 2018 | $128.14M(+13.8%) | $32.75M(-47.4%) | $128.14M(-2.2%) |
| Sep 2018 | - | $62.26M(+895.8%) | $130.97M(+22.1%) |
| Jun 2018 | - | $6.25M(-76.7%) | $107.30M(-15.1%) |
| Mar 2018 | - | $26.88M(-24.4%) | $126.43M(+12.3%) |
| Dec 2017 | $112.61M | $35.58M(-7.8%) | $112.61M(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $38.58M(+52.0%) | $101.67M(+11.8%) |
| Jun 2017 | - | $25.39M(+94.4%) | $90.92M(+11.3%) |
| Mar 2017 | - | $13.06M(-47.0%) | $81.69M(+25.3%) |
| Dec 2016 | $65.21M(+101.1%) | $24.64M(-11.5%) | $65.21M(+9.3%) |
| Sep 2016 | - | $27.84M(+72.4%) | $59.63M(+79.5%) |
| Jun 2016 | - | $16.15M(-572.2%) | $33.22M(+12.8%) |
| Mar 2016 | - | -$3.42M(-117.9%) | $29.45M(-9.2%) |
| Dec 2015 | $32.42M(-229.2%) | $19.06M(+1240.6%) | $32.42M(+66.2%) |
| Sep 2015 | - | $1.42M(-88.5%) | $19.50M(+46.9%) |
| Jun 2015 | - | $12.39M(-2828.9%) | $13.27M(-314.9%) |
| Mar 2015 | - | -$454.00K(-107.4%) | -$6.17M(-75.4%) |
| Dec 2014 | -$25.09M(-57.9%) | $6.14M(-227.8%) | -$25.09M(-38.2%) |
| Sep 2014 | - | -$4.81M(-31.9%) | -$40.58M(-22.0%) |
| Jun 2014 | - | -$7.06M(-63.6%) | -$52.01M(-15.3%) |
| Mar 2014 | - | -$19.37M(+107.2%) | -$61.37M(+3.0%) |
| Dec 2013 | -$59.59M(+24.3%) | -$9.35M(-42.4%) | -$59.59M(-10.5%) |
| Sep 2013 | - | -$16.23M(-1.1%) | -$66.59M(+7.3%) |
| Jun 2013 | - | -$16.42M(-6.7%) | -$62.05M(+11.9%) |
| Mar 2013 | - | -$17.59M(+7.7%) | -$55.44M(+15.6%) |
| Dec 2012 | -$47.95M(+30.1%) | -$16.34M(+39.7%) | -$47.95M(+19.7%) |
| Sep 2012 | - | -$11.70M(+19.2%) | -$40.06M(+6.7%) |
| Jun 2012 | - | -$9.81M(-3.0%) | -$37.55M(+1.5%) |
| Mar 2012 | - | -$10.11M(+19.6%) | -$36.97M(+0.3%) |
| Dec 2011 | -$36.87M(+12.3%) | -$8.45M(-8.0%) | -$36.87M(+29.7%) |
| Sep 2011 | - | -$9.18M(-0.6%) | -$28.42M(+47.7%) |
| Jun 2011 | - | -$9.24M(-7.7%) | -$19.24M(+92.3%) |
| Mar 2011 | - | -$10.00M | -$10.00M |
| Dec 2010 | -$32.84M(-1810.3%) | - | - |
| Dec 2009 | $1.92M(-106.4%) | - | - |
| Dec 2008 | -$29.79M(+98.0%) | - | - |
| Dec 2007 | -$15.04M | - | - |
FAQ
- What is Supernus Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual FCF year-on-year change?
- What is Supernus Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly FCF year-on-year change?
- What is Supernus Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM FCF year-on-year change?
What is Supernus Pharmaceuticals annual free cash flow?
The current annual FCF of SUPN is $171.23M
What is the all time high annual FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual free cash flow is $171.23M
What is Supernus Pharmaceuticals annual FCF year-on-year change?
Over the past year, SUPN annual free cash flow has changed by +$60.69M (+54.91%)
What is Supernus Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SUPN is $30.27M
What is the all time high quarterly FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly free cash flow is $91.42M
What is Supernus Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SUPN quarterly free cash flow has changed by -$7.88M (-20.66%)
What is Supernus Pharmaceuticals TTM free cash flow?
The current TTM FCF of SUPN is $163.34M
What is the all time high TTM FCF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM free cash flow is $178.10M
What is Supernus Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SUPN TTM free cash flow has changed by +$63.51M (+63.61%)